US Broker Ratings

Cel-Sci Corporation (CVM) Stock Analysis: Unraveling a 583% Potential Upside in Biotech

Cel-Sci Corporation (NASDAQ: CVM) presents a compelling narrative for investors intrigued by the high-risk, high-reward landscape of biotechnology stocks. With an impressive potential upside of 583.06%, as suggested by analyst..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Look at the 132% Potential Upside in Biotech Innovation

For investors eyeing the biotechnology sector, Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) presents a compelling opportunity with its promising potential upside of 132.56%. The company, known for its pioneering work in..

Avanos Medical, Inc. (AVNS) Stock Analysis: A Closer Look at Valuation Metrics and Growth Potential in the Healthcare Sector

Avanos Medical, Inc. (NYSE: AVNS) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alpharetta, Georgia, Avanos is known for its innovative medical..

Zenas BioPharma, Inc. (ZBIO) Investor Outlook: High Potential Upside of 79.72% in the Biotech Sector

Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its promising position in the biotechnology industry. With a focus on transformative immunology-based therapies, the company stands out..

COMPASS Pathways Plc (CMPS) Investor Outlook: Exploring a 282% Potential Upside in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology company in the mental health space, has been gaining attention for its innovative approach to treating some of the most challenging mental..

Upstream Bio, Inc. (UPB) Stock Report: A Biotech Gem with a Potential 471% Upside

Upstream Bio, Inc. (UPB), a promising player in the burgeoning biotechnology sector, is rapidly gaining attention in the healthcare industry. With a market capitalization of $452.84 million, this clinical-stage biopharmaceutical..

Akebia Therapeutics, Inc. (AKBA): Investor Outlook Highlights a 209.86% Potential Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA), a prominent player in the healthcare sector specializing in biopharmaceuticals, is capturing investor attention with its remarkable potential upside of 209.86%. This Cambridge, Massachusetts-based company..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 263.95% Potential Upside in the Burgeoning Gene Therapy Space

Investors looking to capitalize on the growing field of gene therapy may find compelling reasons to consider MeiraGTx Holdings plc (NASDAQ: MGTX). As a clinical-stage genetic medicines company, MeiraGTx is..

Butterfly Network, Inc. (BFLY) Stock Analysis: 40% Potential Upside with Cutting-Edge Medical Devices

For investors keen on the healthcare sector, Butterfly Network, Inc. (NASDAQ: BFLY) offers an intriguing opportunity with notable potential upside. This medical device company is at the forefront of ultrasound..

Intellia Therapeutics (NTLA) Stock Analysis: Exploring Nearly 92% Upside Potential in Biotech

Intellia Therapeutics, Inc. (NASDAQ: NTLA), a prominent player in the biotechnology sector, is gaining attention for its ambitious foray into gene editing treatments. With the current stock price at $13.15..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential

KalVista Pharmaceuticals, Inc. (KALV) is making waves in the biotechnology sector with a robust pipeline aimed at addressing unmet medical needs in hereditary angioedema (HAE). Headquartered in Framingham, Massachusetts, this..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a 423% Potential Upside in the Biotech Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a New York-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating neurological disorders. With a market capitalization..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Potential Challenges with a Promising Revenue Growth

InnovAge Holding Corp. (NASDAQ: INNV), a company firmly rooted in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $1.13..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges with 25% Upside Potential

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a name that resonates with potential amidst the biotechnology sector, a field known for its innovative disruptions and transformative impact. While the company’s..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Growth Potential and Challenges in the Cannabis Sector

As the cannabis industry continues to evolve, Cronos Group Inc. (NASDAQ: CRON) stands out as a key player, leveraging its presence across Canada, Israel, and other international markets. With a..

Auna SA (AUNA) Stock Analysis: Potential 24% Upside in the Healthcare Sector

Auna SA (AUNA), a Luxembourg-based healthcare provider, is garnering attention from investors due to its robust potential upside. With a market cap of $428.54 million, Auna offers an intriguing investment..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Gem with 137.90% Potential Upside

Xencor, Inc. (NASDAQ: XNCR) is capturing the attention of investors seeking opportunities within the healthcare sector, particularly in the biotechnology industry. With a market capitalization of $888.86 million, Xencor is..

Sonida Senior Living, Inc. (SNDA): Performance Highlights Amidst Navigating Challenges in the Healthcare Sector

Sonida Senior Living, Inc. (SNDA) stands as a significant player in the United States’ senior housing sector, offering a range of specialized services from independent and assisted living to memory..

Eton Pharmaceuticals, Inc. (ETON) Stock Report: Exploring a Promising 49.25% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector focusing on rare diseases, is capturing investor attention with its impressive growth trajectory and substantial upside potential. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds